A review on 3D printing for cardiovascularregeneration: A focus on bioprinted cardiac valves

Authors

  • Devangini Sharma Author
  • Mrunali Patel Author
  • Jignesh Mevada Author

Keywords:

3D printing, regenerative medicine, extrusion based bioprinting, hydrogel, cardiovascular disease, cardiac valves, scaffold

Abstract

The emergence of 3D bioprinting has marked a pivotal advancement in regenerative medicine, particularly within the scope of cardiovascular repair. By enabling the creation of patient-specific valves that are anatomically and functionally tailored, 3D printing offers promising solutions to enhance treatment efficacy and long-term patient care. Furthermore, bioprinted valves hold the potential for regenerative capabilities, advancing the field of cardiovascular tissue engineering. Understanding these advancements is crucial for shaping future research directions and clinical applications aimed at improving cardiovascular health outcomes. This review meticulously examines the current landscape and prospective developments in 3D bioprinting applications for cardiovascular regeneration, with a focused analysis on bioprinted cardiac valves.

Bioprinting, a method for constructing complex tissue architectures through a layer-by-layer deposition process, offers unparalleled precision and customization in tissue engineering. This paper begins by elucidating the principles of bioprinting, its necessity in modern medicine, and the various bioprinter technologies, including inkjet, extrusion, and laser-assisted bioprinters. Each type presents distinct advantages that render them suitable for different cardiovascular tissue engineering applications. Hydrogels used as bioinks in bioprinting play a crucial role in forming biocompatible and functional tissue structures. This review explores the different hydrogel types, emphasizing their properties and appropriateness for cardiac tissue engineering.

The core focus is the application of 3D bioprinting in fabricating cardiac valves. Bioprinted cardiac valves represent a significant advancement over traditional valve replacement therapies, offering tailored solutions that potentially mitigate the risks of rejection and reduce the dependence on lifelong medication. The paper also examines the potential of 3D bioprinting in creating cardiovascular assist devices (CVADs), which highlights its capabilities in addressing severe cardiovascular conditions and ponders upon the recent progress in the bioprinting of cardiac valves, discussing key studies and their implications for clinical application. It further identifies the current challenges and outlines future research directions necessary to overcome these obstacles and enhance the efficacy of 3D bioprinting in treating cardiovascular diseases.

In summary, 3D bioprinting presents transformative potential in cardiovascular medicine. By enabling the fabrication of patient-specific cardiac tissues and devices, it opens avenues for more effective and personalized therapeutic strategies for cardiovascular diseases. Ongoing advancements are anticipated to significantly improve the management and outcomes of cardiovascular conditions.

Downloads

Published

2025-01-01